Imunon/$IMNN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Imunon
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
Ticker
$IMNN
Sector
Primary listing
Employees
25
Headquarters
Website
Imunon Metrics
BasicAdvanced
$10M
-
-$9.54
1.93
-
Price and volume
Market cap
$10M
Beta
1.93
52-week high
$41.22
52-week low
$2.86
Average daily volume
27K
Financial strength
Current ratio
1.729
Quick ratio
1.251
Long term debt to equity
17.348
Total debt to equity
27.004
Profitability
EBITDA (TTM)
-14.281
Management effectiveness
Return on assets (TTM)
-77.72%
Return on equity (TTM)
-233.50%
Valuation
Price to book
2.11
Price to tangible book (TTM)
2.11
Price to free cash flow (TTM)
-0.298
Free cash flow yield (TTM)
-335.36%
Free cash flow per share (TTM)
-9.96
Growth
Earnings per share change (TTM)
-53.23%
3-year earnings per share growth (CAGR)
-44.12%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Imunon stock?
Imunon (IMNN) has a market cap of $10M as of March 20, 2026.
What is the P/E ratio for Imunon stock?
The price to earnings (P/E) ratio for Imunon (IMNN) stock is 0 as of March 20, 2026.
Does Imunon stock pay dividends?
No, Imunon (IMNN) stock does not pay dividends to its shareholders as of March 20, 2026.
When is the next Imunon dividend payment date?
Imunon (IMNN) stock does not pay dividends to its shareholders.
What is the beta indicator for Imunon?
Imunon (IMNN) has a beta rating of 1.93. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.